Apimeds Pharmaceuticals US (APUS) Cash from Operations (2024 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Cash from Operations came in at 3818202.0 in Q4 2025, down 3732.92% YoY from 105100.07 in Q4 2024, and down 121.2% on a QoQ basis from 1726166.0 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Cash from Operations (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 2 years of Cash from Operations data on file, last reported at 3818202.0 in Q4 2025.
- Quarterly Cash from Operations fell 3732.92% year-over-year to 3818202.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 8925777.0 (down 1116.83% YoY) and the FY2025 annual result came in at 8925777.0, down 1116.83% from the prior year.
- Cash from Operations retreated to 3818202.0 in Q4 2025, from 1726166.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 20313.0 in Q1 2025 to a low of 3818202.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Apimeds Pharmaceuticals US | 7.68 Mn | 7.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.82 Mn |
| Dec 31, 2025 | -3.82 Mn |
| Sep 30, 2025 | -1.73 Mn |
| Sep 30, 2025 | -1.73 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | -20,313.00 |
| Mar 31, 2025 | -20,313.00 |
| Dec 31, 2024 | -99,616.00 |
| Dec 31, 2024 | -99,616.00 |
| Sep 30, 2024 | -186,755.00 |
| Sep 30, 2024 | -186,755.00 |
| Jun 30, 2024 | -184,055.00 |
| Jun 30, 2024 | -184,055.00 |
| Mar 31, 2024 | -263,100.00 |
| Mar 31, 2024 | -263,100.00 |